Get the Stockscreener App
5.84
1.04%
0.06
Pre-market:
5.84
Atai Life Sciences N V stock is traded at $5.84, with a volume of 4.46M.
It is up +1.04% in the last 24 hours and up +10.40% over the past month.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
See More
Previous Close:
$5.78
Open:
$5.76
24h Volume:
4.46M
Relative Volume:
0.72
Market Cap:
$1.25B
Revenue:
$2.59M
Net Income/Loss:
$-137.89M
P/E Ratio:
-7.2099
EPS:
-0.81
Net Cash Flow:
$-69.76M
1W Performance:
+1.21%
1M Performance:
+10.40%
6M Performance:
+289.33%
1Y Performance:
+450.94%
1-Day Range:
$5.66
$5.915
1-Week Range:
$5.66
$6.23
52-Week Range:
$1.05
$6.75
Atai Life Sciences N V Stock (ATAI) Company Profile
Name
Atai Life Sciences N V
Sector
Industry
Phone
49 89 2153 9035
Address
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Compare ATAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATAI
Atai Life Sciences N V
|
5.84 | 1.54B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Jul-29-25 | Initiated | Oppenheimer | Outperform |
| Nov-18-24 | Reiterated | H.C. Wainwright | Buy |
| Apr-03-24 | Upgrade | Maxim Group | Hold → Buy |
| Nov-01-22 | Initiated | Loop Capital | Buy |
| Nov-30-21 | Initiated | Maxim Group | Buy |
| Nov-11-21 | Initiated | ROTH Capital | Buy |
| Oct-18-21 | Initiated | H.C. Wainwright | Buy |
| Sep-01-21 | Initiated | Jefferies | Buy |
| Jul-13-21 | Initiated | Berenberg | Buy |
| Jul-13-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | Cantor Fitzgerald | Buy |
| Jul-13-21 | Initiated | Citigroup | Buy |
| Jul-13-21 | Initiated | Cowen | Outperform |
| Jul-13-21 | Initiated | Credit Suisse | Outperform |
| Jul-13-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-08-21 | Initiated | Aegis Capital | Buy |
View All
Atai Life Sciences N V Stock (ATAI) Latest News
Published on: 2025-11-03 03:02:35 - newser.com
Is Atai Life Sciences N.V. stock a defensive play in 2025July 2025 Opening Moves & Safe Entry Point Alerts - newser.com
Why analysts recommend Atai Life Sciences N.V. (9VC) stockEarnings Risk Summary & Safe Entry Zone Tips - newser.com
Will Atai Life Sciences N.V. stock reach all time highs in 2025Market Trend Report & Safe Capital Growth Tips - newser.com
Will Atai Life Sciences N.V. stock sustain high P E ratiosWeekly Profit Analysis & Growth Focused Investment Plans - newser.com
Why Atai Life Sciences N.V. (9VC) stock appears on watchlistsJuly 2025 Volume & Fast Moving Market Watchlists - newser.com
Ranking Atai Life Sciences N.V. among high performing stocks via tools2025 Dividend Review & Risk Managed Investment Strategies - newser.com
Is Atai Life Sciences N.V. (9VC) stock nearing a technical breakoutMarket Performance Summary & AI Powered Market Trend Analysis - newser.com
Will Atai Life Sciences N.V. (9VC) stock justify high valuationMarket Trend Review & Free Daily Entry Point Trade Alerts - newser.com
Published on: 2025-11-01 04:43:33 - newser.com
Will Atai Life Sciences N.V. (9VC) stock test record highs in 2025Portfolio Performance Report & AI Forecast Swing Trade Picks - newser.com
Why Atai Life Sciences N.V. stock appeals to dividend seekersJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - newser.com
Understanding Atai Life Sciences N.V.’s price movement2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
Will Atai Life Sciences N.V. (9VC) stock outperform energy sector in 2025July 2025 Sector Moves & Community Consensus Trade Alerts - newser.com
Can Atai Life Sciences N.V. stock resist sector downturns2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com
Atai Life Sciences N.V. stock trend forecastTrade Volume Summary & Fast Moving Market Watchlists - newser.com
Chart based analysis of Atai Life Sciences N.V. trendsProfit Target & Step-by-Step Trade Execution Guides - newser.com
Published on: 2025-10-30 23:24:14 - newser.com
Combining machine learning predictions for Atai Life Sciences N.V.Quarterly Growth Report & Capital Efficient Trade Techniques - newser.com
Building trade automation scripts for Atai Life Sciences N.V.Earnings Miss & Risk Managed Trade Strategies - newser.com
Can machine learning forecast Atai Life Sciences N.V. recovery2025 Market Overview & Risk Managed Trade Strategies - newser.com
Why Atai Life Sciences N.V. stock attracts high net worth investorsEarnings Summary Report & AI Enhanced Trading Signals - fcp.pa.gov.br
Is Atai Life Sciences N.V. stock recession proof2025 Earnings Impact & AI Based Buy/Sell Signal Reports - fcp.pa.gov.br
Atai Life Sciences N V Stock (ATAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):